3 jobs found in bala cynwyd

*Dental Solutions of Bala Cynwyd *is looking for a *Part-Time Dental Hygienist* to join our clinical team. The hygienist we hire will provide a high level of patient care and satisfaction while operating in a team-based environment. We are committed to providing comprehensive, personalized care in a warm and welcoming environment, prioritizing patient comfort and advanced treatments for optimal oral health. *Position Overview:* As a Dental Hygienist at *Dental Solutions*, you'll provide exceptional care through routine cleanings, assessments, and education, all while supporting a dynamic team of dental professionals. We offer a friendly, growth-oriented workplace where patient comfort is always a priority. *Schedule:* Every other Wednesday (8:40-5:00) Fridays (8:40-2:00) *What we offer:* * Competitive hourly rate based on experience + bonus potential * Growth Opportunities: Support for professional growth and continuing education * Modern office with the latest dental...

Description: The Company: This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Their lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich's ataxia. Friedreich's ataxia is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. The company has between 60 and 70 employees and has assembled an experienced management team, each of whom has over 20 years of pharmaceutical industry experience. The management team, employees, and consultants have significant expertise in discovery, nonclinical and clinical development, regulatory affairs, commercialization, and the development of manufacturing processes...

Description: The Company: Larimar Therapeutics Inc. is a publicly held clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Our lead product candidate, Nomlabofusp (CTI-1601), is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich's ataxia. Friedreich's ataxia is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. We have assembled an experienced management team, each of whom has over 20 years of pharmaceutical industry experience. Our management team, employees, and consultants have significant expertise in discovery, nonclinical and clinical development, regulatory affairs, manufacturing and CMC. Our company's strategy is to become a leader in the...